Genetron Holdings Ltd

Company Profile

Genetron Holdings Ltd had its IPO on 2020-06-15 under the ticker symbol GTH.

The company operates in the Healthcare sector and Diagnostics & Research industry. Genetron Holdings Ltd has a staff strength of 993 employees.

Stock update

Shares of Genetron Holdings Ltd opened at $0.91 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0.9 - $0.93, and closed at $0.9.

This is a +0.23% increase from the previous day's closing price.

A total volume of 13,937 shares were traded at the close of the day’s session.

In the last one week, shares of Genetron Holdings Ltd have slipped by -4.56%.

Genetron Holdings Ltd's Key Ratios

Genetron Holdings Ltd has a market cap of $86.06 million, indicating a price to book ratio of 0.7301 and a price to sales ratio of 0.1771.

In the last 12-months Genetron Holdings Ltd’s revenue was $650.71 million with a gross profit of $337.97 million and an EBITDA of $-651244032. The EBITDA ratio measures Genetron Holdings Ltd's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Genetron Holdings Ltd’s operating margin was -107.87% while its return on assets stood at -35.2% with a return of equity of -92.2%.

In Q2, Genetron Holdings Ltd’s quarterly earnings growth was a positive 0% while revenue growth was a positive 37.1%.

Genetron Holdings Ltd’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.18 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Genetron Holdings Ltd’s profitability.

Genetron Holdings Ltd stock is trading at a EV to sales ratio of 0.0889 and a EV to EBITDA ratio of -0.0758. Its price to sales ratio in the trailing 12-months stood at 0.1771.

Genetron Holdings Ltd stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$1.30 billion

Total Liabilities

$350.10 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Genetron Holdings Ltd ended 2024 with $1.30 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.30 billion while shareholder equity stood at $891.95 million.

Genetron Holdings Ltd ended 2024 with $0 in deferred long-term liabilities, $350.10 million in other current liabilities, 61000.00 in common stock, $-5846200000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $327.55 million and cash and short-term investments were $472.68 million. The company’s total short-term debt was $111,936,000 while long-term debt stood at $19.19 million.

Genetron Holdings Ltd’s total current assets stands at $989.76 million while long-term investments were $49.20 million and short-term investments were $145.13 million. Its net receivables were $432.18 million compared to accounts payable of $53.69 million and inventory worth $55.02 million.

In 2024, Genetron Holdings Ltd's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Genetron Holdings Ltd paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0.9

52-Week High

$1.27

52-Week Low

$0.731

Analyst Target Price

$1.35

Genetron Holdings Ltd stock is currently trading at $0.9 per share. It touched a 52-week high of $1.27 and a 52-week low of $1.27. Analysts tracking the stock have a 12-month average target price of $1.35.

Its 50-day moving average was $0.92 and 200-day moving average was $0.98 The short ratio stood at 1.84 indicating a short percent outstanding of 0%.

Around 597.5% of the company’s stock are held by insiders while 1159.1% are held by institutions.